086040 — Biotoxtech Co Share Price
Last trade - 00:00- KR₩49bn
- KR₩86bn
- KR₩41bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.21 | ||
| Price to Tang. Book | 1.27 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.78% | ||
| Return on Equity | -14% | ||
| Operating Margin | -20.6% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 26,428.63 | 32,717.39 | 37,291.74 | 32,630.98 | 41,341.49 | n/a | n/a | 9.84% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +147.4 | -81.42 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioToxTech Co Ltd is a Korea-based company engaged in the research of non-clinical evaluation business. The Company provides safety evaluation research, efficacy evaluation research, analysis research and other related services. The Company's safety evaluation research provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests; efficacy evaluation research provides efficacy evaluation of medical supplies, health supplements and cosmetics; analysis research provides pharmacokinetics (PK) tests and toxicokinetic (TK) tests services, as well as validation and bio analysis services. The Company provides its evaluation services to pharmaceuticals, chemicals, health functional foods, functional cosmetics and pesticides areas.
Directors
- Jong Gu Kang CEO (62)
- Myeong Cheol Shin OTH (40)
- Yong Bae Park DRC (48)
- Seong Jin Baek DRC (43)
- Dong Yil Kim DRC (45)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 23rd, 2000
- Public Since
- September 21st, 2007
- No. of Shareholders
- 15,585
- No. of Employees
- 230
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 15,720,789
- Address
- 53, Yeongudanji-ro, Ochang-eup, Cheongwo, CHEONGJU, 28115
- Web
- https://www.biotoxtech.com/
- Phone
- +82 432107777
- Auditors
- Dongseong Accounting Corporation
Upcoming Events for 086040
Similar to 086040
Chabiotech Co
Korea Exchange - KOSDAQ
DreamCIS
Korea Exchange - KOSDAQ
DT&CRO Co
Korea Exchange - KOSDAQ
GC Cell
Korea Exchange - KOSDAQ
Labgenomics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:36 UTC, shares in Biotoxtech Co are trading at KR₩3,095. This share price information is delayed by 15 minutes.
Shares in Biotoxtech Co last closed at KR₩3,095 and the price had moved by -43.29% over the past 365 days. In terms of relative price strength the Biotoxtech Co share price has underperformed the FTSE Developed Asia Pacific Index by -42.64% over the past year.
The overall consensus recommendation for Biotoxtech Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBiotoxtech Co does not currently pay a dividend.
Biotoxtech Co does not currently pay a dividend.
Biotoxtech Co does not currently pay a dividend.
To buy shares in Biotoxtech Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩3,095, shares in Biotoxtech Co had a market capitalisation of KR₩49bn.
Here are the trading details for Biotoxtech Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 086040
Based on an overall assessment of its quality, value and momentum Biotoxtech Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Biotoxtech Co is KR₩15,000. That is 384.65% above the last closing price of KR₩3,095.
Analysts covering Biotoxtech Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biotoxtech Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -26.13%.
As of the last closing price of KR₩3,095, shares in Biotoxtech Co were trading -18.11% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biotoxtech Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,095.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Biotoxtech Co's management team is headed by:
- Jong Gu Kang - CEO
- Myeong Cheol Shin - OTH
- Yong Bae Park - DRC
- Seong Jin Baek - DRC
- Dong Yil Kim - DRC